Literature DB >> 28830900

Mycoplasma pneumoniae-induced rash and mucositis: a recently described entity.

Rui Pedro Santos1, Marta Silva2, Ana Paula Vieira1, Celeste Brito1.   

Abstract

Mycoplasmapneumoniae is a common cause of respiratory infections. Although most cases are mild, some patients have extrapulmonary complications including mucocutaneous eruptions including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and erythemamultiforme (EM). Recently, a new entity, called M. pneumoniae-induced rash and mucositis (MIRM) was described. The authors present a clinical case difficult to classify attending to the classical classification of epidermolytic syndromes that meets the criteria proposed for the diagnosis of MIRM. The mucocutaneous disease associated with M. pneumoniae presents predominant mucositis, with scarce or absent cutaneous involvement. Because of the distinct morphology, pathophysiology and benign clinical course, MIRM should be considered as a new entity, distinct from SJS/TEN and EM. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Dermatology; Medical Education; Pneumonia (infectious Disease)

Mesh:

Substances:

Year:  2017        PMID: 28830900      PMCID: PMC5623246          DOI: 10.1136/bcr-2017-220768

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

Review 1.  Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions: fact or fiction?

Authors:  Peter C Schalock; James G H Dinulos
Journal:  J Am Acad Dermatol       Date:  2005-02       Impact factor: 11.527

2.  Recurrent erythema multiforme in association with recurrent Mycoplasma pneumoniae infections.

Authors:  Martine Grosber; Marina Alexandre; Ewa Poszepczynska-Guigné; Jean Revuz; Jean-Claude Roujeau
Journal:  J Am Acad Dermatol       Date:  2007-05       Impact factor: 11.527

3.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Jui-Yung Yang; Shih-Chi Su; Shien-Ping Huang; Chun-Yu Wei; See-Wen Chin; Chien-Chun Chiou; Sung-Chao Chu; Hsin-Chun Ho; Chih-Hsun Yang; Chi-Fang Lu; Jer-Yuarn Wu; You-Di Liao; Yuan-Tsong Chen
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

Review 4.  Mycoplasma pneumoniae-induced cutaneous disease.

Authors:  Peter C Schalock; James G H Dinulos
Journal:  Int J Dermatol       Date:  2009-07       Impact factor: 2.736

5.  Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.

Authors:  S Kusunoki; M Shiina; I Kanazawa
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

6.  Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.

Authors:  S H Kardaun; P Sekula; L Valeyrie-Allanore; Y Liss; C Y Chu; D Creamer; A Sidoroff; L Naldi; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2013-11       Impact factor: 9.302

7.  Persistent B-cell lymphopenia, multiorgan disease, and erythema multiforme caused by Mycoplasma pneumoniae infection.

Authors:  Baldassarre Martire; Caterina Foti; Nicoletta Cassano; Rosalba Buquicchio; Giovanni Carlo Del Vecchio; Domenico De Mattia
Journal:  Pediatr Dermatol       Date:  2005 Nov-Dec       Impact factor: 1.588

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Mycoplasma pneumonia-associated mucositis.

Authors:  Cyril Varghese; Korosh Sharain; Joseph Skalski; Kannan Ramar
Journal:  BMJ Case Rep       Date:  2014-03-13

Review 10.  Mycoplasma pneumoniae-associated mucositis--case report and systematic review of literature.

Authors:  I Vujic; A Shroff; M Grzelka; C Posch; B Monshi; M Sanlorenzo; S Ortiz-Urda; K Rappersberger
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-02-17       Impact factor: 6.166

View more
  6 in total

1.  Ocular manifestations of mycoplasma-induced rash and mucositis.

Authors:  Haoxing D Jin; R Michael Siatkowski; Rhea L Siatkowski
Journal:  J AAPOS       Date:  2020-07-02       Impact factor: 1.220

2.  Mycoplasma pneumoniae-associated Mucositis: A Recently Described Entity.

Authors:  Inês Zão; Fani Ribeiro; Valter Rocha; Pedro Neto; Carla Matias; Gorete Jesus
Journal:  Eur J Case Rep Intern Med       Date:  2018-11-28

3.  Not a Drug Rash!

Authors:  Ananta Khurana; Anusha Katare; Kabir Sardana; Aastha Aggarwal; Ram Kishan Gautam
Journal:  Indian Dermatol Online J       Date:  2020-01-13

4.  Clonal expansion of CD4+CD8+ T cells in an adult patient with Mycoplasma pneumoniae-associated Erythema multiforme majus.

Authors:  Sarah M Volkers; Christian Meisel; Dorothea Terhorst-Molawi; Guido J Burbach; Dirk Schürmann; Norbert Suttorp; Leif E Sander
Journal:  Allergy Asthma Clin Immunol       Date:  2021-02-10       Impact factor: 3.406

5.  Case Report and Literature Review: Clinical Characteristics of 10 Children With Mycoplasma pneumoniae-Induced Rash and Mucositis.

Authors:  Ning Chen; Miao Li
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418

6.  Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.

Authors:  Rochelle Tonkin; Malika Ladha; Nicole Johnson; William F Astle; Ami Britton; Neil H Shear; Luis Murguía-Favela; Michele Ramien
Journal:  SAGE Open Med Case Rep       Date:  2022-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.